65: Bridging Science and Practice in Acute Migraine Therapy

from Pharmacy Focus · host Pharmacy Times

You can find Dr. Joshi on LinkedIn here.Read more essential insights on PharmacyTimes.com.

Episode metadata supplied by the publisher feed · Published Nov 21, 2025

Embed this episode

Attribution link and audio player

What this episode covers

In this episode of Pharmacy Focus, headache specialist Shivang Joshi, MD, MPH, PRh, FAHS discusses the clinical rationale, practical considerations, and pharmacy implications of Symbravo, a fixed-dose combination of meloxicam and rizatriptan approved for acute migraine in adults.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

65: Bridging Science and Practice in Acute Migraine Therapy

0:00 20:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Pharmacy Focus?

This episode is 20 minutes long.

When was this Pharmacy Focus episode published?

This episode was published on November 21, 2025.

Can I download this Pharmacy Focus episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!